Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Bausch Health Companies Q2 Adj. EPS $0.91 Misses $0.96 Estimate, Sales $2.530B Beat $2.481B Estimate

Author: Benzinga Newsdesk | July 30, 2025 04:32pm
Bausch Health Companies (NYSE:BHC) reported quarterly earnings of $0.91 per share which missed the analyst consensus estimate of $0.96 by 5.21 percent. This is a 7.14 percent decrease over earnings of $0.98 per share from the same period last year. The company reported quarterly sales of $2.530 billion which beat the analyst consensus estimate of $2.481 billion by 1.96 percent. This is a 5.29 percent increase over sales of $2.403 billion the same period last year.

Posted In: BHC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist